SLC6A4 and depressive disorder: Indeed, the results herein open the possibility of performing additional in vivo experiments with SERT allosteric inhibitors in combination with current effective orthosteric inhibitors, to probe for improved therapeutic effects using behavioral paradigms for depression or anxiety.